Anzeige
Mehr »
Login
Dienstag, 03.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 02.08.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
02.08.BIMobject AB: BIMobject: Interim Report April-June 202440Second quarter financial highlightsARR in constant currencies of MSEK 138.4 (128.1) at end of quarter, +8%Net sales of MSEK 41.8 (39.6), +6%, including a currency effect of +1%Net sales from recurring...
► Artikel lesen
02.08.Helport AI Limited and Tristar Acquisition I Corp. Announce Closing on Reduced $5.5 Million PIPE Investment Concurrently with Closing of Business Combination118SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, "Helport"), an AI technology company serving enterprises' customer...
► Artikel lesen
02.08.CSE Bulletin: Reinstatement - Tantalex Lithium Resources Corporation (TTX)90le 2 août/August 2024 Effective immediately, Tantalex Lithium Resources Corporation will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. ____________________________ Avec...
► Artikel lesen
02.08.Ginkgo Bioworks to Hold Special Meeting of Shareholders114Special meeting to take place virtually on August 14, 2024 at 4:00 pm ET BOSTON, Aug. 2, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform...
► Artikel lesen
02.08.OCI N.V.: OCI Global Reports Q2 2024 Results273Financial Highlights • OCI Global (Euronext: OCI) reported total Q2 2024 revenues of $1,211 million, a 12% reduction YoY, and total Q2 2024 adjusted EBITDA of $296 million, a decrease of 9% YoY....
► Artikel lesen
02.08.Zevra Therapeutics: FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C316CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that the U.S. Food and...
► Artikel lesen
02.08.Digicann Ventures Inc.: Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction413/Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or the...
► Artikel lesen
02.08.Bluewater Acquisition Corp. and AlphaDelta Management Corp. Announce Termination of LOI163CALGARY, Alberta, and VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bluewater Acquisition Corp. ("Bluewater") (TSXV: BAQ.P) and AlphaDelta Management Corp. ("ADM") jointly announce...
► Artikel lesen
02.08.JOYY Inc.: JOYY Announces Leadership Transition150SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (Nasdaq: YY) ("JOYY" or the "Company"), a global technology company, today announced that its board of directors (the "Board") has approved a...
► Artikel lesen
02.08.Chibougamau Independent Mines Inc.: Termination of TomaGold's Option for the Acquisition of Chibougamau's East Block209ROUYN-NORANDA, Québec, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC...
► Artikel lesen
02.08.Tourmaline Bio, Inc.: Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024164Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and monthly subcutaneous administration...
► Artikel lesen
02.08.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)129SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
► Artikel lesen
02.08.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)162SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development...
► Artikel lesen
02.08.Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)145WALTHAM, Mass. and DUBLIN, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies...
► Artikel lesen
02.08.TWC Enterprises Limited Announces Second Quarter 2024 Results and Eligible Dividend126KING CITY, Ontario, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Consolidated Financial Highlights (unaudited) (in thousands of dollars except per share amounts)Three months endedSix months endedJune...
► Artikel lesen
02.08.NEXGOLD MINING CORP: NexGold Mining Announces New OTCQX Ticker Symbol265TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG) (OTCQX: NXGCF) (the "Company" or "NexGold") is pleased to announce that it will begin trading at market open on August...
► Artikel lesen
02.08.Helport AI Limited and Tristar Acquisition I Corp. Announce Closing of Business Combination and listing on Nasdaq215SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, "Helport") (Nasdaq: HPAI), an AI technology company serving enterprise...
► Artikel lesen
02.08.Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)205BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on July 31, 2024...
► Artikel lesen
02.08.JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency279Chengdu, China, Aug. 02, 2024 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (the "Company"), a company that specializes in providing one-stop comprehensive education supporting services to adult...
► Artikel lesen
02.08.electroCore, Inc.: electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)186ROCKAWAY, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August...
► Artikel lesen
Seite:  Weiter >>